GlassScriptPhysician profile
Jan J Shim
NPI 1265417299
$1,061.30
in general payments reported to CMS, 2019-2025
13 companies · $20.00 in 2025
The $20.00 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
See the full distribution for Gastroenterology (Internal Medicine)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $256 · 2020: $19.20 · 2022: $87.79 · 2023: $389 · 2024: $289 · 2025: $20.00.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $658 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $20.00 · Grant: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $657.85 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $20.00 |
| Grant | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Celgene Corporation | $205.59 | 2022-2024 | Zeposia |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $176.66 | 2019-2023 | Xifaxan, Plenvu, Trulance |
| Thd America, INC. | $153.86 | 2024 | |
| Janssen Scientific Affairs, LLC | $125.00 | 2019 | |
| Novo Nordisk INC | $125.00 | 2023 | |
| Abbvie INC. | $110.48 | 2022-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $35.88 | 2022-2024 | Entyvio |
| Regeneron Healthcare Solutions, INC. | $35.14 | 2023-2024 | Dupixent |
| Qol Medical, LLC | $34.12 | 2020-2022 | |
| Janssen Biotech, INC. | $15.54 | 2023 | Stelara |
| Ardelyx, INC. | $15.42 | 2023 | Ibsrela |
| Genzyme Corporation | $15.11 | 2023 | |
| Redhill Biopharma INC. | $13.50 | 2023 | Aemcolo, Talicia, Movantik |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jan Shim listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.